2.1. Methylene Blue (MB) Completely Reverses the Inhibitory Effects of Tau on Plasma Membrane Ca2+-ATPase (PMCA) Activity in Human Brain Membranes of Alzheimer’s Disease Patients and Control Subjects. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.